文献速递头颈外科

接受原发经口机器人手术联合颈淋巴清扫的口咽鳞状细胞癌患者中的隐匿性淋巴结病变与隐匿性结外扩展

Occult Nodal Disease and Occult Extranodal Extension in Patients With Oropharyngeal Squamous Cell Carcinoma Undergoing Primary Transoral Robotic Surgery With Neck Dissection.
PubMed 文献 · JAMA Otolaryngol Head Neck Surg · 2019-01-01

这项回顾性多中心队列研究纳入92例病理T1-2期口咽鳞状细胞癌患者,评估经口机器人手术联合颈淋巴清扫术后淋巴结分期上调及隐匿性结外扩展的发生率。影像学无淋巴结病变的18例中5例(28%)存在隐匿性病理淋巴结病变;32例影像学无淋巴结病变或仅单个转移淋巴结者中7例(22%)因多个阳性淋巴结而病理分期上调。24例(27%)存在病理结外扩展,39例中5例(13%)为影像学无证据的隐匿性结外扩展。

要点

  • 影像学无淋巴结病变的18例中5例(28%)存在隐匿性病理淋巴结病变
  • 影像学无淋巴结病变或仅单个转移淋巴结的32例中7例(22%)因多个阳性淋巴结而病理分期上调
  • 24例(27%)存在病理结外扩展,39例中5例(13%)为影像学无证据的隐匿性结外扩展

核心结论

  • 对接受经口机器人手术联合颈淋巴清扫的口咽鳞状细胞癌患者,术前预测病理分期仍具挑战性。
  • 淋巴结大小、肿瘤大小和位置无助于预测结外扩展,而影像学上淋巴结的存在及淋巴结分类可能有助于预测结外扩展。
  • 作者认为,基于隐匿性淋巴结分期上调及结外扩展,小部分患者可能受益于术前影像未预测到的进一步辅助治疗。

研究设计与样本

  • 回顾性、多中心队列研究,纳入92例病理T1-2期口咽鳞状细胞癌患者,来自2家美国机构(Albert Einstein College of Medicine, Bronx, New York, n=38;Icahn School of Medicine at Mount Sinai, New York, New York, n=39)和1家加拿大机构(Princess Margaret Hospital, Toronto, n=15)。
  • 患者于2007年8月至2016年12月接受经口机器人手术联合颈淋巴清扫。
  • 各中心一名对最终病理诊断设盲的神经放射科医生审阅术前影像,并与手术病理比较,采用美国癌症联合委员会分期手册第八版进行肿瘤分期。
  • 统计分析于2018年12月18日进行。

主要发现

  • 92例符合纳入标准的患者中,76例(83%)为男性,手术时平均(标准差)年龄为59.5(10.5)岁;有p16状态结果的70例患者中70例(84%)为阳性。
  • 影像学无淋巴结病变的18例患者中,5例(28%)存在隐匿性病理淋巴结病变。
  • 影像学无淋巴结病变或仅单个转移淋巴结的32例患者中,7例(22%)因多个阳性淋巴结而接受病理分期上调,表明实施了预先影像后未预料到的额外辅助治疗。
  • 第八版分期中,12例(13%)发生病理淋巴结分期上调,12例(13%)发生病理淋巴结分期下调。
  • 队列中24例(27%)存在病理结外扩展,39例中5例(13%)在影像学无证据的情况下存在隐匿性结外扩展。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: The historically reported rates of subclinical cervical nodal metastases in oropharyngeal squamous cell carcinoma (OPSCC) predate the emergence of human papillomavirus as the predominant causative agent. The rate of occult nodal disease with changing etiology of OPSCC is not known, and it is challenging to anticipate which patients will be upstaged postoperatively and will require adjuvant therapy. OBJECTIVE: To assess the rate of nodal upstaging and occult extranodal extension (ENE) in a multi-institutional population of patients with pathologic (p)T1-2 OPSCC treated by transoral robotic surgery and neck dissection. DESIGN, SETTING AND PARTICIPANTS: This retrospective, multicenter cohort study of 92 participants at 2 US institutions (Albert Einstein College of Medicine, Bronx, New York [n = 38], and Icahn School of Medicine at Mount Sinai, New York, New York [n = 39]) and 1 Canadian institution (Princess Margaret Hospital, Toronto [n = 15]) examined the rate of postoperative pathologic upstaging for 92 patients with pT1-2 OPSCC undergoing transoral robotic surgery with neck dissection from August 2007 to December 2016. A neuroradiologist at each site blinded to final pathologic diagnosis reviewed preoperative imaging; these findings were compared with operative pathology and applied for tumor staging using the eighth edition of the American Joint Committee on Cancer Cancer Staging Manual. The statistical analysis was performed on December 18, 2018. MAIN OUTCOMES AND MEASURES: Occult pathologic nodal disease and change in nodal category postoperatively. RESULTS: Of 92 patients who met the inclusion criteria, 76 (83%) were male, and they had a mean (SD) age at surgery of 59.5 (10.5) years; 70 patients (84%) with available p16 status were positive. Five of 18 patients (28%) who had no evidence of nodal disease on imaging had occult pathologic nodal disease. Seven of 32 patients (22%) presenting with no nodal disease or with a single metastatic node on imaging received pathologic upstaging because of multiple positive nodes, indicating implementation of additional adjuvant treatment not anticipated after a priori imaging. Changes included 12 patients (13%) who had pathologic nodal upstaging and 12 (13%) with pathologic nodal downstaging in the eighth edition of staging. In the cohort, 24 patients (27%) had pathologic ENE, and 5 of 39 patients (13%) had occult ENE in the absence of radiographic evidence. CONCLUSIONS AND RELEVANCE: Predicting pathologic staging preoperatively for patients with OPSCC undergoing transoral robotic surgery and neck dissection remains a challenge. Although nodal size, tumor size, and location do not help predict ENE, the presence of nodes on imaging and nodal category may help predict ENE. Our findings suggest a small proportion of patients might benefit from further adjuvant therapies not predicted by preoperative imaging based on occult nodal upstaging and ENE.

来源:JAMA Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. McMullen CP, Garneau J, Weimar E, et al. Occult Nodal Disease and Occult Extranodal Extension in Patients With Oropharyngeal Squamous Cell Carcinoma Undergoing Primary Transoral Robotic Surgery With Neck Dissection. JAMA Otolaryngol Head Neck Surg. 2019. PMID: 31219521. doi:10.1001/jamaoto.2019.1186

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。